Can One Treatment of BI 655066 Cure Psoriasis?

BI 655066 was well tolerated and associated with "rapid, substantial, and durable" clinical improvement in patients with moderate-to-severe psoriasis, supporting a central role for IL-23 in psoriasis pathogenesis.